"Further delays in [Greece's] negotiations [with private bondholders] would lead to renewed nervousness on the financial markets"
- Anja Hochberg, head of investment strategy at Credit Suisse Group AG
Swiss stocks erased two-day gains on Wednesday as health-care shares dropped on lower-than-expected 2011 financial results of Lonza Group AG, Novartis and Roche Holding AG.
The Swiss blue-chip index SMI, a measure of the largest and most actively traded companies, shed 1.01%, or 61.74 points, to 6,073.36. The broader Swiss Performance Index declined 0.91%, or 50.30 points, to 5,488.71.
KOF Economic Research Agency is to announce its economic barometer on Friday. The index is derived via combined reading of 12 economic indicators related to banking confidence, production, new orders, consumer confidence and housing.
© Dukascopy Bank